Send us a textWe've seen some big #federal #Cannabis #news in the headlines this week when President Biden signed a historic bill approving cannabis research. A national banking association has made demands urging the Senate to take action on the SAFE Banking Act. President Joe Biden today signed into law a bill that streamlines access to marijuana for medical research. The new law is expected to speed the issuance of government permits to scientists who want to study cannabis, whose medicinal promise has been widely touted but remains, with a few exceptions, unproven. It will also expedite applications from producers—including universities—that want to grow and distribute the drug for research. It also obliges the federal government to make sure an adequate, uninterrupted supply of marijuana is available to scientists. “We will now be able to treat marijuana like we treat any other substance or pharmaceutical for which we hope there is potential benefit. We will be able to subject it to rigorous scientific trial,” says Representative Andy Harris (R–MD), a physician and former National Institutes of Health (NIH)–funded researcher who helped usher the bipartisan legislation through Congress. https://www.science.org/content/article/new-u-s-law-promises-light-marijuana-research The four co-chairs of the Congressional Cannabis Caucus—Blumenauer and Reps. Barbara Lee (D-CA), Dave Joyce (R-OH) and Brian Mast (R-FL)—released a joint statement following the president’s signing. “For decades, the federal government has stood in the way of science and progress—peddling a misguided and discriminatory approach to cannabis. Today marks a monumental step in remedying our federal cannabis laws,” they said. “The Medical Marijuana and Cannabidiol Research Expansion Act will make it easier to study the impacts and potential of cannabis.” “Research is foundational for the path forward on cannabis policy. Research is essential to better understand the therapeutic benefits of cannabis that have the potential to help millions of Americans struggling with chronic pain, PTSD, multiple sclerosis, anxiety disorders and more. We celebrate the enactment of this critical and long-overdue legislation, and we know there is much more to do to remedy the ongoing harms of the failed war on drugs. Our caucus will continue working to reimagine the federal government’s approach to cannabis and enact further reforms. In the coming weeks, we are committed to passing subsequent bipartisan, common-sense proposals like the SAFE Banking package, the Veterans Equal Access Act, the PREPARE Act, and the Veterans Medical Marijuana Safe Harbor Act.” https://www.whitehouse.gov/briefing-room/legislation/2022/12/02/bills-signed-h-j-res-100-h-r-8454-s-3826-and-s-3884/ H.R. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,” which establishes a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development; Thank you to Representatives Blumenauer, Harris, Griffith, Joyce, Mace, and Perlmutter, Delegate Norton, and Senators Feinstein, Grassley, Schatz, Durbin, Klobuchar, Tillis, Kaine, Ernst, Tester, and Murkowski for their leadership. Get in touch with us: 🌱 We can help with your cannabis business. Here is our Linktree. (https://bit.ly/3jHLITp) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj) cannabis nSupport the showGet our newsletter: https://bit.ly/3VEn9vu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related